Updated Jul 16, 2026
Fox David Morton has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $50K.

Fox David Morton is identified in the latest SEC filing as a director of MediWound Ltd. MediWound Ltd is a biotechnology company focused on wound care. As of the 2026-06-02 SEC filing, Morton serves on MediWound's board. Public biographical information beyond this SEC filing is not readily available, so the published bio is limited to his role as a director for MediWound Ltd.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | MDWD | MediWound Ltd. | P — Open-market purchase | 1.8K | $13.99 | $25K |
| 2026-06-02 | MDWD | MediWound Ltd. | P — Open-market purchase | 10 | $14.23 | $142 |
| 2026-06-02 | MDWD | MediWound Ltd. | P — Open-market purchase | 1.7K | $14.22 | $25K |
Fox David Morton is identified in the latest SEC filing as a director of MediWound Ltd. MediWound Ltd is a biotechnology company focused on wound care. As of the 2026-06-02 SEC filing, Morton serves on MediWound's board. Public biographical information beyond this SEC filing is not readily available, so the published bio is limited to his role as a director for MediWound Ltd.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 3 open-market purchases ($50K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Fox David Morton profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.